Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46534
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKudelina, O. M.-
dc.contributor.authorKhloponin, D. P.-
dc.contributor.authorMaklyakov, Y. S.-
dc.contributor.authorZaika, V. G.-
dc.contributor.authorGantsgorn, E. V.-
dc.date.accessioned2022-04-29T10:06:20Z-
dc.date.available2022-04-29T10:06:20Z-
dc.date.issued2016-
dc.identifier.citationEvaluation efficiency of modern antidepressants by means of quantative pharmaco-EEG / O. M. Kudelina [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol. 2, № 4.- P. 12-20. - Doi: 10.18413/2500-235X-2016-2 - 4-12-20. - Refer.: p. 20.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/46534-
dc.description.abstractAn example perspective way to improve the pharmacotherapy of depression is to combine SSIRs with representatives of other groups of drugs. Great interest from this point of view is the hormone of pineal gland - melatonin (MT), which is an important element of the non-specific antistress system of body. Evaluation efficiency of the above regimes of pharmacotherapy of depressive frustration showed, that the application of valdoxan, and also combination fluoxetine+melaxen favorably affects the course of the disease and contributes to a more rapid normalization of bioelectric activity of brain than fluoxetine in isolation, both experimentally and clinicallyru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subjectdepressionru
dc.subjectratsru
dc.subjectpatientsru
dc.subjectvaldoxanru
dc.subjectfluoxetineru
dc.subjectmelaxenru
dc.subjectpharmaco-EEGru
dc.titleEvaluation efficiency of modern antidepressants by means of quantative pharmaco-EEGru
dc.typeArticleru
Appears in Collections:Vol. 2, № 4

Files in This Item:
File Description SizeFormat 
Kidelina_Evaluation_16.pdf709 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.